Archiv der Pharmazie

Article	Citations
Selective cytotoxicity of ent‐kaurene diterpenoids isolated from Baccharis lateralis and Baccharis retusa (Asteraceae)	220
Structure‐guided identification of a selective sulfonamide‐based inhibitor targeting the human carbonic anhydrase VA isoform	208
Combating DC‐SIGN‐mediated SARS‐CoV‐2 dissemination by glycan‐mimicking polymers	75
Cover Picture: Arch Pharm (1/2024)	68
What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors	58
GOAT rs10096097 and CREB1 rs6740584 single nucleotide polymorphisms are associated with type 2 diabetes mellitus in Egyptians	51
Fabrication of sulfobutylether‐β‐cyclodextrin/glabridin inclusion complex for promoting bioactivities	46
Discovery of xanthone‐based nitric oxide donors targeting biofilm clearance	45
Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds	44
Synthesis of novel pyrimido[4,5‐b]quinoline derivatives as dual EGFR/HER2 inhibitors as anticancer agents	42
In vitro antiviral activity of favipiravir and its 6‐ and 3‐O‐substituted derivatives against coronavirus: Acetylation leads to improvement of antiviral activity	41
Piperlongumine and its derivatives against cancer: A recent update and future prospective	40
Review on the pharmacological effects and pharmacokinetics of scutellarein	40
Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2	39
Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5‐nitrothiophene derivatives for anticancer activity	38
A novel class for carbonic anhydrases inhibitors and evaluation of their non‐zinc binding	38
Synthesis, antimycobacterial, cytotoxicity, anti‐inflammatory, in silico studies and molecular dynamics of pyrazole‐embedded thiazolidin‐4‐one hybrids	34
Design, synthesis, and activity evaluation of novel multitargeted l‐tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease	32
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers	32
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review	30
Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells	28
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives	27
Thiazole‐based SARS‐CoV‐2 protease (COV Mpro) inhibitors: Design, synthesis, enzyme inhibition, and molecular modeling simulations	27
	26
Aripiprazole as an Inhibitor of the EGFR/PI3K/AKT Signaling Pathway and Sensitizer of MPA Suppressed Progestin‐Resistant Endometrial Cancer Cells	26

Cover Picture: Arch Pharm (2/2024)	26
Cover Picture: Arch Pharm (9/2021)	25
Editorial Board: Arch Pharm (10/2023)	24
	23
New chimeric HDAC inhibitors for the treatment of colorectal cancer	22
Liposomal formulation of model pentathiepin improves solubility and stability toward glutathione while preserving anticancer activity	22
Combining chemical profiles and biological abilities of different extracts from Tanacetum nitens (Boiss. & Noë) Grierson using network pharmacology	22
The discovery of a new nonbile acid modulator of Takeda G protein‐coupled receptor 5: An integrated computational approach	21
Evaluation of the effect of carvedilol orodispersible tablets on ischemia–reperfusion injury and flap viability in rats: An in vivo study	21
Cover Picture: Arch Pharm (7/2023)	21
Novel benzothiazole/benzothiazole thiazolidine‐2,4‐dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies	21
Design, synthesis and biological evaluation of (E)‐kojyl‐styryl‐sulfones: Novel recilisib hybrids as promising radioprotectors	21
Novel pyrazolo[3,4‐b]pyridine derivatives: Synthesis, structure–activity relationship studies, and regulation of the AMPK/70S6K pathway	21
Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond	20
Aromatic linker variations in novel dopamine D2 and D3 receptor ligands	20
Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors	20
Structural determinants of sphingosine‐1‐phosphate receptor selectivity	20
Spirooxadiazoline‐oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells	19
Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic KV7 channel openers: Exploration of a nicotinamide scaffold	19
Optimization of 4‐amino‐pyridazin‐3(2H)‐one as a valid core scaffold for FABP4 inhibitors	19
Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation	19
Novel tetrahydropyran‐triazole hybrids with antiproliferative activity against human tumor cells	19
Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus‐Induced Nephrotoxicity Through Targeting the miR‐22/HMGB‐1/TLR4/MyD88/NF‐κB Trajectory	18
Discover the Power of Lithospermic Acid as Human Carbonic Anhydrase VA and Pancreatic Lipase Inhibitor Through In Silico and In Vitro Studies	17
Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents	17
Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis	16
	16
Design, synthesis, and α‐glucosidase‐inhibitory activity of phenoxy‐biscoumarin–N‐phenylacetamide hybrids	16
Uncovering chemical profiles, biological potentials, and protection effect against ECM destruction in H2O2‐treated HDF cells of the extracts of Stachys tundjeliensis	16
Peripheral (E)‐2‐[(4‐hydroxybenzylidene)‐3,4‐dihydronaphthalen‐1(2H)‐one)]‐coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors	16
The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review	16
Design, synthesis, and evaluation of dual‐target inhibitors for the treatment of Alzheimer's disease	16
N‐[4‐(Benzyloxy)‐3‐methoxybenzyl)]adamantane‐1‐amine (DZH2), a dual CCR5 and CXCR4 inhibitor as a potential agent against triple negative breast cancer	15
Cover Picture: Arch Pharm (6/2022)	15
5‐methyl‐2‐carboxamidepyrrole‐based novel dual mPGES‐1/sEH inhibitors as promising anticancer candidates	15
Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents	15
Piperazine‐based P2X4 receptor antagonists	15
Conjugates of amiridine and thiouracil derivatives as effective inhibitors of butyrylcholinesterase with the potential to block β‐amyloid aggregation	15
Issue Information: Arch Pharm (5/2025)	15
Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity	14
	14
Safe and selective anticancer agents from tetrafluorinated azobenzene‐imidazolium ionic liquids: Synthesis, characterization, and cytotoxic effects	14
Unveiling the chemistry of 1,3,4‐oxadiazoles and thiadiazols: A comprehensive review	14
Implication of Central β2 Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease	14
Cytotoxic derivatives of dichloroacetic acid and some metal complexes	13
New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents	13
Quantum dots in the biomedical world: A smart advanced nanocarrier for multiple venues application	13
Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action	13
Microwave‐assisted N‐alkylation of amines with alcohols catalyzed by MnCl2: Anticancer, docking, and DFT studies	13
Discovery of potent CSK inhibitors through integrated virtual screening and molecular dynamic simulation	13

Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential	13
Review of β‐carboline and its derivatives as selective MAO‐A inhibitors	13
Synthesis of new phenothiazine derivatives: Molecular docking, assessment of cytotoxic activity and oxidant–antioxidant properties on PCS‐201‐012, HT‐29, and SH‐SY5Y cell lines	13
Design, synthesis, and biological evaluation of simplified tetrahydroisoquinoline analogs	13
A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives	13
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase	13
Screening of Chelidonium majus isoquinoline alkaloids reveals berberine and chelidonine as selective ligands for the nuclear receptors RORβ and HNF4α, respectively	12
Synthesis and evaluation of novel almazole D analogs as anticancer agents	12
	12
Cover Picture: Arch Pharm (6/2023)	12
Unlocking the potential of edible Ulva sp. seaweeds: Metabolomic profiling, neuroprotective mechanisms, and implications for Parkinson's disease management	12
Biology‐oriented drug synthesis and evaluation of secnidazole esters as novel enzyme ınhibitors	12
Synthesis, Characterization and Evaluation of Antioxidant and Antimicrobial Activities of Novel Isatin Derivatives	12
	12
Design, synthesis, and evaluation of novel 3,4‐isoxazolediamide derivatives for the combination treatment of azole‐resistant candidiasis	12
Synthesis and photodynamic activity of new 5‐[(E)‐2‐(3‐alkoxy‐1‐phenyl‐1H‐pyrazol‐4‐yl)ethenyl]‐2‐phenyl‐3H‐indoles	12
Leishmanicidal and cytotoxic activities and 4D‐QSAR of 2‐arylidene indan‐1,3‐diones	12
Synthesis of novel benzylamine antimycotics and evaluation of their antimycotic potency	12
Silybin loaded Ag‐nanoparticles as a drug delivery system for solid tumor theragnosis: Extraction, radioiodination, and biodistribution study	12
	12
New PEPPSI‐Pd‐NHC complexes bearing 4‐hydroxyphenylethyl group: Synthesis, characterization, molecular docking, and bioactivity properties	12
Design, synthesis, acetylcholinesterase, butyrylcholinesterase, and amyloid‐β aggregation inhibition studies of substituted 4,4ʹ‐diimine/4,4ʹ‐diazobiphenyl derivatives	11
Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development	11
Synthesis, Antituberculosis Evaluation and Structure–Activity Relationships of New SQ109 Analogs	11
5,6‐Dihydrotetrazolo[1,5‐c]quinazolines: Toxicity prediction, synthesis, antimicrobial activity, molecular docking, and perspectives	11
Purification of a novel protein with cytotoxicity against non‐small‐cell lung cancer cells from Boletus bicolor	11
Advances in polysaccharide‐based materials for biomedical and pharmaceutical applications: A comprehensive review	11
Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction	11
A new series of hydrazones as small‐molecule aldose reductase inhibitors	11
The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens	11
Up‐to‐date studies regarding the determination of melatonin by chromatographic methods	11
New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes	11
Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies	11
Issue Information: Arch Pharm (4/2025)	11
Tandem synthesis, cytotoxicity, and in silico study of new 1,3,4‐oxadiazoles as potential thymidylate synthase inhibitors	11
	10
	10
A novel indole derivative, 2‐{3‐[1‐(benzylsulfonyl)piperidin‐4‐yl]‐2‐methyl‐1H‐indol‐1‐yl}‐1‐(pyrrolidin‐1‐yl)ethenone, suppresses hedgehog signaling and drug‐resistant tumor growth	10
Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors	10
Editorial Board: Arch Pharm (9/2021)	10
Design, synthesis of novel thiazole‐thiomorpholine derivatives and evaluation of their anticancer activity via in vitro and in silico studies	10
Inhibitory effects of 190 compounds against SARS‐CoV‐2 Mpro protein: Molecular docking interactions	10
Editorial Board: Arch Pharm (9/2023)	10
Issue Information: Arch Pharm (4/2024)	10
	10
ω‐(5‐Phenyl‐2H‐tetrazol‐2‐yl)alkyl‐substituted hydrazides and related compounds as inhibitors of amine oxidase copper containing 3 (AOC3)	10
Design, synthesis, and structure–activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors	9
Synthesis, structure–activity relationship, and biological evaluation of quinolines for development of anticancer agents	9
Ginkgo biloba in the management of the COVID‐19 severity	9
Greenness‐by‐design approach for developing novel UV spectrophotometric methodologies resolving a quaternary overlapping mixture	9
Тhio‐containing pteridines: Synthesis, modification, and biological activity	9
Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration	9
Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4‐oxadiazole derivatives	9
New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies	9
Synthesis, characterization, biochemical, and molecular modeling studies of carvacrol‐based new thiosemicarbazide and 1,3,4‐thiadiazole derivatives	9
The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases	9
Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4‐oxadiazole derivatives: Synthesis, in vitro screening, and computational studies	9
A virtual library of small molecules mimicking dipeptides	9
An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020–2024)	9
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors	9
Health benefits of fraxetin: From chemistry to medicine	9
New 1H‐indole‐2,3‐dione 3‐thiosemicarbazones with 3‐sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors	9
Targeting the binding pocket of the fluorophore 8‐anilinonaphthalene‐1‐sulfonic acid in the bacterial enzyme MurA	9
Self‐microemulsifying drug delivery system‐based gastroretentive in situ raft of pazopanib with enhanced solubility and bioavailability	8
Issue Information: Arch Pharm (12/2024)	8
1,3,4‐Thiadiazole and 1,2,4‐triazole‐5‐thione derivatives bearing 2‐pentyl‐5‐phenyl‐2,4‐dihydro‐3H‐1,2,4‐triazole‐3‐one ring: Synthesis, molecular docking, urease inhibition, and crystal struct	8
Eco‐friendly approaches to 1,3,4‐oxadiazole derivatives: A comprehensive review of green synthetic strategies	8
3‐[3‐(Phenalkylamino)cyclohexyl]phenols: Synthesis, biological activity, and in silico investigation of a naltrexone‐derived novel class of MOR‐antagonists	8
Editorial Board: Arch Pharm (9/2022)	8
Emerging green synthetic routes for thiazole and its derivatives: Current perspectives	8
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions	8
Metabolic profiling of Verbena bonariensis L. extract by LC/MS and evaluation of the hepatoprotective potential with isoniazid‐ and rifampicin‐induced hepatotoxicity in rats	8
Issue Information: Arch Pharm (1/2025)	8
Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors	8
The anti‐breast cancer potential of indole/isatin hybrids	8
Binding of boswellic acids to functional proteins of the SARS‐CoV‐2 virus: Bioinformatic studies	8
Cover Picture: Arch Pharm (3/2022)	8
Research progress on the pathogenesis of psoriasis and its small molecule inhibitors	8
Proapoptotic effects of halogenated bis‐phenylthiourea derivatives in cancer cells	8
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells	8

Various pharmacological agents in the pipeline against intractable epilepsy	8
New phenylthiosemicarbazide‐phenoxy‐1,2,3‐triazole‐N‐phenylacetamides as dual inhibitors against α‐glucosidase and PTP‐1B for the treatment of type 2 diabetes	8
Design and synthesis of benzofuran‐ and naphthalene‐fused thiazinones as antimycobacterial agents	8
Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking	8
Synthesis and biological evaluation of sulfonamide‐based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae	8
Cover Picture: Arch Pharm (1/2022)	8
Dihydropyrimidinones as potent anticancer agents: Insight into the structure–activity relationship	8
Editorial Board: Arch Pharm (6/2022)	7
In‐vitro and in‐silico investigations of SLC‐0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors	7
Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐b]pyridazine hybrid derivatives as VEGFR selective inhibitors	7
Recent green approaches for the synthesis of pyrazolo[3,4‐d]pyrimidines: A mini review	7
The current landscape of coumarin hybrids with antibreast cancer therapeutic applications: An updated review	7
Novel RP‐HPLC method for estimation of a newly developed combination of tizanidine and etoricoxib in rat plasma: Eight criteria for greens evaluation	7
New azaaurone derivatives as potential multitarget agents in HIV‐TB coinfection	7
Cover Picture: Arch Pharm (8/2023)	7
1,2,3‐Triazole hybrids as anticancer agents: A review	7
Synthesis of benzylated amine‐substituted xanthone derivatives and their antioxidant and anti‐inflammatory activities	7
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases	7
Cover Picture: Arch Pharm (10/2023)	7
Development and in vitro antiviral activity of ivermectin liposomes as a potential drug carrier system	7
4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator	7
	7
Synthesis and evaluation of febrifugine derivatives as anticoccidial agents	7
EGB761 ameliorates mild cognitive impairment by inhibiting the pyroptosis and apoptosis in both in vivo and in vitro experiments	7
	7
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate	7
Development of fluorinated nicotinonitriles and fused candidates as antimicrobial, antibiofilm, and enzyme inhibitors	7
Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin‐mediated vesicular trafficking pathway	7
A review of recent advances in anticancer activity and SAR of pyrazole derivatives	7
Synthesis of selenophene‐based chalcone analogs and assessment of their biological activity as anticancer agents	7
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects	7
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluatio	7
Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities	7
Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis	7
Design, synthesis, and biological evaluation of coumarin analogs as novel LSD1 inhibitors	7
Chicoric acid alleviates rotenone‐induced motor dysfunction in mice: Targeting PI3K/AKT/caspase‐3‐associated apoptosis and neuroinflammation	7
Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway	7
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19	7
Novel isoxazoline‐linked 1,3,4‐thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation	7
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties	6
A decade of research effort in synthesis, biological activity assessments, and mechanistic investigations of sulfamethazine‐incorporating molecules	6
Introduction to artificial intelligence and deep learning using interactive electronic programming notebooks	6
Design and synthesis of novel substituted s‐triazines tethered benzenesulfonamides as potential antimicrobial candidates: Antibiofilm and bacterial protein permeability assessments	6
Azobenzene derivatives with activity against drug‐resistant Candida albicans and Candida auris	6
Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation	6
Green synthesis of pregabalin‐stabilized gold nanoclusters and their applications in sensing and drug release	6
Enhancing Polyacrylonitrile Nanofibers Antiviral Activity Using Greenly Synthesized Silver Nanoparticles	6
2,2,2‐Trifluoroethanol‐mediated hydroarylation of fluorinated alkynes with indoles: Application to diindolylmethanes	6
Repurposing of 5‐nitrofuran‐3,5‐disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agents	6
Editorial Board: Arch Pharm (11/2021)	6
1H‐1,2,3‐Triazole−4H‐chromene−D‐glucose hybrid compounds: Synthesis and inhibitory activity against Mycobacterium tuberculosis protein tyrosine phosphatase B	6
Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells	6
Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation	6
	6
Novel N‐pyrocatechoyl and N‐pyrogalloyl hydrazone antioxidants endowed with cytotoxic and antibacterial activity	6
6‐Aminocoumarin oxime‐ether/sulfonamides as selective hCA IX and XII inhibitors: Synthesis, evaluation, and molecular dynamics studies	6
Recent advances in the development of celecoxib analogs as anticancer agents: A review	6
Discovery of novel harmine derivatives as GSK‐3β/DYRK1A dual inhibitors for Alzheimer's disease treatment	6
Facile one‐pot synthesis of N‐pyridinylaminonaphthol derivatives and their antibacterial evaluation against multidrug‐resistant Staphylococcus aureus	6
The synergy between nucleotide biosynthesis inhibitors and antiviral nucleosides: New opportunities against viral infections?	6
Cover Picture: Arch Pharm (9/2023)	6
Cardioprotective effect of silymarin nanoemulsion on 5‐fluorouracil‐induced cardiotoxicity in rats	6
Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors	6
Simultaneous analysis of oxytetracycline hydrochloride, lidocaine, and bromhexine hydrochloride in the presence of many interfering excipients	6
The effects of morin and methotrexate on pentose phosphate pathway enzymes and GR/GST/TrxR enzyme activities: An in vivo and in silico study	6
TERRA G‐quadruplex stabilization behind the anti‐multiple myeloma activity: Novel insights about resveratrol pleiotropic effects	6
The anti‐Acinetobacter baumannii therapeutic potential of azole hybrids: A mini‐review	6
Enhancing the anticancer effect of metformin through nanoencapsulation: Apoptotic induction, inflammatory reduction, and suppression of cell migration in colorectal cancer cells	6
Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review	6
Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor	6
Issue Information: Arch Pharm (11/2024)	5
Design, synthesis, and biological evaluation of aminopyridine derivatives as novel tropomyosin receptor kinase inhibitors	5
	5
Design, synthesis, and biological evaluation of isatin‐indole‐3‐carboxaldehyde hybrids as a new class of xanthine oxidase inhibitors	5
Bioavailability enhancement of coenzyme Q10: An update of novel approaches	5
Cover Picture: Arch Pharm (5/2022)	5
Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment	5
Antioxidant activity, phytochemical composition, and antitumor capacity of Amazonian fruits taperebá (Spondias mombin) and murici (Byrsonima crassifolia)	5
Radiosynthesis and whole‐body distribution in mice of a 18F‐labeled azepino[4,3‐b]indole‐1‐one derivative with multimodal activity for the treatment of Alzheimer's disease	5
	5
Discrepancies in the German Pharmacopoeia procedure for quality control of Quillaja saponin extracts	5
The anticancer activity of carbazole alkaloids	5
Synthesis and biological studies of pyrimidine derivatives targeting metabolic enzymes	5
UHPLC‐ESI‐QTOF‐MS metabolite profiles of different extracts from Pelargonium endlicherianum parts and their biological properties based on network pharmacological approaches	5
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure‐based virtual screening	5
Multipathway regulation induced by 4‐(phenylsulfonyl)morpholine derivatives against triple‐negative breast cancer	5
Potential of triazines in Alzheimer's disease: A versatile privileged scaffold	5
Discovery and optimization of 3‐(indolin‐5‐yloxy)pyridin‐2‐amine derivatives as potent necroptosis inhibitors	5
Synthesis of novel 2‐acetamide‐5‐phenylthio‐1,3,4‐thiadiazole‐containing phenyl urea derivatives as potential VEGFR‐2 inhibitors	5
Editorial Board: Arch Pharm (7/2022)	5
6‐aryloxy‐2‐aminopyrimidine‐benzonitrile hybrids as anti‐infective agents: Synthesis, bioevaluation, and molecular docking	5
Chrysin: A polyedric flavone as a tool to explore new phytotherapeutic applications and drug design	5
A new series of thiosemicarbazone‐based anti‐inflammatory agents exerting their action through cyclooxygenase inhibition	5
Imaging of the calcium activated potassium channel 3.1 (KCa3.1) in vivo using a senicapoc‐derived positron emission tomography tracer	5
Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents	5